Boston Scientific Corporation
BSX
$100.02
$0.970.98%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.08% | 8.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.08% | 8.54% | |||
| Cost of Revenue | -7.03% | 12.54% | |||
| Gross Profit | 3.52% | 6.70% | |||
| SG&A Expenses | 1.46% | 7.45% | |||
| Depreciation & Amortization | 0.00% | 2.74% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.50% | 10.52% | |||
| Operating Income | 11.35% | 0.64% | |||
| Income Before Tax | -0.32% | 16.89% | |||
| Income Tax Expenses | 25.34% | 9.77% | |||
| Earnings from Continuing Operations | -5.03% | 18.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 0.00% | |||
| Net Income | -5.27% | 18.25% | |||
| EBIT | 11.35% | 0.64% | |||
| EBITDA | 8.84% | 1.35% | |||
| EPS Basic | -5.39% | 18.01% | |||
| Normalized Basic EPS | -27.95% | 55.64% | |||
| EPS Diluted | -3.87% | 17.78% | |||
| Normalized Diluted EPS | -27.95% | 55.91% | |||
| Average Basic Shares Outstanding | 0.12% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||